{
    "RADCURE-3567": {
        "question": "Age: 85.9, Sex: Male, ECOG PS: ECOG 0, Smoking PY: 0, Smoking Status: Non-smoker, Ds Site: Larynx, Subsite: Glottis, T: T2, N: N0, M : M0, Stage: II, Path: Squamous Cell Carcinoma, HPV: none, Tx Modality: RT alone, Chemo? : none, Dose: 66.0, Fx: 33, Local: none, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-negative cases involving the larynx glottis subsite. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "Step-by-step analysis as a radiation oncologist:\n\n1. The provided bounding box coordinates are [[251, 182, 60, 251, 202, 66], [251, 182, 60, 251, 202, 66]]. Both boxes are identical, indicating a single region of interest (ROI) within the CT scan.\n\n2. The coordinates are normalized relative to the image size, but the exact anatomical location is not explicitly stated. However, given the context of a head and neck CT scan, these coordinates likely correspond to a small, localized region.\n\n3. The ROI appears to be a small volume, possibly representing a lesion, lymph node, or a small organ substructure.\n\n4. Without additional clinical data (e.g., tumor staging, HPV status, pathology), it is difficult to definitively characterize the abnormality or its impact on prognosis.\n\n5. From a radiation oncology perspective, the size and location of the ROI are critical for planning treatment fields and dose constraints to minimize toxicity while ensuring adequate tumor coverage.\n\n6. If this ROI corresponds to a tumor or involved lymph node, its small size and localized nature may suggest a favorable prognosis, especially if HPV-positive and without nodal or distant metastases.\n\n7. Conversely, if this ROI represents a critical organ at risk (OAR), careful dose planning is necessary to avoid complications.\n\nFinal answer: Alive",
        "initial_assessment_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-radiation oncologist": "Answer:no",
        "Round 2-Turn 1-ask_gap_review_assessment-radiation oncologist": "---\nAnswer: no\nReason: current expertise covers required scope\n---",
        "Round 2-role-comment": "radiation oncologist:alive",
        "Round 2-num_agents": 1,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}